1. Home
  2. AMLX vs DOMO Comparison

AMLX vs DOMO Comparison

Compare AMLX & DOMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMLX
  • DOMO
  • Stock Information
  • Founded
  • AMLX 2014
  • DOMO 2010
  • Country
  • AMLX United States
  • DOMO United States
  • Employees
  • AMLX N/A
  • DOMO N/A
  • Industry
  • AMLX Biotechnology: Pharmaceutical Preparations
  • DOMO Computer Software: Prepackaged Software
  • Sector
  • AMLX Health Care
  • DOMO Technology
  • Exchange
  • AMLX Nasdaq
  • DOMO Nasdaq
  • Market Cap
  • AMLX 330.5M
  • DOMO 324.2M
  • IPO Year
  • AMLX 2022
  • DOMO 2018
  • Fundamental
  • Price
  • AMLX $3.56
  • DOMO $7.51
  • Analyst Decision
  • AMLX Buy
  • DOMO Hold
  • Analyst Count
  • AMLX 4
  • DOMO 6
  • Target Price
  • AMLX $7.50
  • DOMO $10.42
  • AVG Volume (30 Days)
  • AMLX 789.6K
  • DOMO 409.3K
  • Earning Date
  • AMLX 05-08-2025
  • DOMO 03-06-2025
  • Dividend Yield
  • AMLX N/A
  • DOMO N/A
  • EPS Growth
  • AMLX N/A
  • DOMO N/A
  • EPS
  • AMLX N/A
  • DOMO N/A
  • Revenue
  • AMLX $87,371,000.00
  • DOMO $317,044,000.00
  • Revenue This Year
  • AMLX N/A
  • DOMO $0.86
  • Revenue Next Year
  • AMLX N/A
  • DOMO $1.94
  • P/E Ratio
  • AMLX N/A
  • DOMO N/A
  • Revenue Growth
  • AMLX N/A
  • DOMO N/A
  • 52 Week Low
  • AMLX $1.58
  • DOMO $6.11
  • 52 Week High
  • AMLX $7.27
  • DOMO $10.15
  • Technical
  • Relative Strength Index (RSI)
  • AMLX 51.34
  • DOMO 48.18
  • Support Level
  • AMLX $3.23
  • DOMO $7.58
  • Resistance Level
  • AMLX $3.83
  • DOMO $9.02
  • Average True Range (ATR)
  • AMLX 0.26
  • DOMO 0.37
  • MACD
  • AMLX -0.01
  • DOMO -0.06
  • Stochastic Oscillator
  • AMLX 58.27
  • DOMO 35.54

About AMLX Amylyx Pharmaceuticals Inc.

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.

About DOMO Domo Inc. Class B

Domo Inc provides a cloud-based platform that digitally connects all the data, systems and people in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company offers a platform to its customers as a subscription-based service. Users receive notifications on any device and immediately act on the invitation, after which the system can write back to the original system of record. The company derives revenue from subscriptions to its cloud-based platform and professional services.

Share on Social Networks: